A Case of Community-Acquired Tuberculosis in an Infant Presenting with Pneumonia Refractory to Antibiotic Therapy

Audra N Iness1, Andrea T Cruz2,3, Scott R Dorfman4

  • 1Baylor College of Medicine, Department of Pediatrics, Houston, TX.

Insights

Infant tuberculosis (TB) is challenging to diagnose, often presenting with non-specific symptoms. This case highlights the importance of considering TB in infants with persistent pneumonia and growth faltering, even without known exposure.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Radiology

Background:

  • Infant tuberculosis (TB) is rare, potentially fatal, and difficult to diagnose due to non-specific symptoms.
  • Community-acquired pneumonia is a common diagnosis in infants, but treatment failure warrants broader differential diagnoses.

Purpose of the Study:

  • To report a case of miliary tuberculosis in a US-born infant with no known TB exposure.
  • To emphasize the diagnostic challenges and clinical considerations for infant TB.
  • To highlight the risk of central nervous system (CNS) involvement in disseminated TB.

Main Methods:

  • Case report of a term infant presenting with respiratory distress and initial misdiagnosis of pneumonia.
  • Diagnostic workup included chest radiography, QuantiFERON-TB Gold test, purified protein derivative (PPD) skin test, and CNS imaging.
  • Treatment response and clinical course were monitored.

Main Results:

  • The infant presented with respiratory distress, initially treated as community-acquired pneumonia without improvement.
  • Imaging revealed findings suggestive of disseminated TB with CNS involvement.
  • Diagnosis was confirmed via QuantiFERON and PPD tests, despite negative initial cerebrospinal fluid (CSF) studies.

Conclusions:

  • In infants with treatment-refractory pneumonia and growth faltering, consider tuberculosis and other alternative etiologies.
  • Disseminated TB poses a high risk for CNS involvement, necessitating brain imaging even with negative CSF results.
  • Early and accurate diagnosis of infant TB is crucial for timely management and improved outcomes.

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
202
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
165
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
266
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
359
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
270
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
274